Tradestie Institutional Equity Comparison Engine

NAIL vs LABU โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

LABU Overall Edge

LABU Captures Institutional Edge (2โ€“0 Pillars ยท 3โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Direxion Daily S&P Biotech Bull 3X Shares (LABU) driven by superior Momentum & Technical, Options & Structure. Fundamentally, NAIL trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus LABU at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, NAIL sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro) against LABU sits in UNCLASSIFIED (12th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
NAIL N/M vs LABU N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner LABU
1Y -39.7% vs +54.0% ยท 52W Pos 16% vs 33%
Options & Structure Winner LABU
BREAKDOWN (17th %ile IV) vs UNCLASSIFIED (12th %ile IV)
NAIL NYSE Arca
Direxion Daily Homebuilders & Supplies Bull 3X Shares
Institutional Equity
$32.48
-1.72% 1D
Market Cap N/A
1M Return +19.81%
1Y Return -39.74%
Forward P/E N/M
Unified AI Score
48.8 / 100 HOLD
Tech 15.0 Fund 42.0 Flow 59.0 Mom 60.0
LABU NYSE Arca
Direxion Daily S&P Biotech Bull 3X Shares
Institutional Equity
$195.22
-9.13% 1D
Market Cap N/A
1M Return -1.83%
1Y Return +53.97%
Forward P/E N/M
Unified AI Score
49.4 / 100 HOLD
Tech 25.0 Fund 39.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NAIL -39.74% LABU +53.97% Spread: +93.71 pp (LABU Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NAIL TTM Op. Margin: N/A LABU TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NAIL vs LABU. Trailing 12-month operating profitability (NAIL N/A vs LABU N/A) and valuation multiples (NAIL N/M vs LABU N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NAIL (0) vs LABU (3)
Institutional Metric NAIL LABU Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 16% ($23โ€“$81) 33% ($124โ€“$342) Stronger Trend LABU
Beta / 30D Volatility Risk Regime 2.84ฮฒ ยท 137% Vol 3.71ฮฒ ยท 119% Vol Lower Realized Risk LABU
Unified Institutional Score Composite Signal 48.8 / 100 (HOLD) 49.4 / 100 (HOLD) Higher Composite LABU

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NAIL vs LABU Buy Guide
NAIL BREAKDOWN
99d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live NAIL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LABU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 12th %ile
IV Regime Compressed (<25th %ile)
Live LABU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NAIL nor LABU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.